⭐️⭐️⭐️⭐️⭐️ "A total no brainer"

⭐️⭐️⭐️⭐️⭐️ "Love this, so easy."

Spots is the easy way to track your skin, mole and cancer changes.

Spots Global Cancer Trial Database for adenosine a2a receptor antagonist

Every month we try and update this database with for adenosine a2a receptor antagonist cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Study titleNCT IDConditionsInterventionsEligibilityOrganizationLink
Study to Assess the Safety, Tolerability and Pharmacokinetic Profile of PBF -509 (80 mg, 160 mg and 240 mg) "After Multiple Oral Doses" in Healthy VolunteersNCT02111330
Parkinson Disea...
PBF-509
Placebo
18 Years - 45 YearsFundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau
Trial of PBF-509 and PDR001 in Patients With Advanced Non-small Cell Lung Cancer (NSCLC)NCT02403193
Non-small Cell ...
PBF-509_80 mg
PBF-509_160 mg
PBF-509_320 mg
PBF-509_640 mg
Combo PBF-509 (...
Combo PBF-509 (...
Combo PBF-509 (...
RP2D (PBF-509+P...
Experimental: R...
18 Years - Palobiofarma SL
Logo

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

spots app storespots app store

Join others from around the world: